Hepatitis C treatment and reinfection surveillance among people who inject drugs in a low-threshold program in Oslo, Norway
Datos Bibliográficos
Cirrhosis · Hepatitis C · Incidence (geometry · Medical prescription · Observational study · Prospective cohort study · Young adult · Hepatitis B Virus Studies · Hepatitis C virus research · Liver Disease Diagnosis and Treatment · Medicine · Internal Medicine · Pediatrics · Pharmacology
Changes in Risk Behaviour Among People With Recent Injecting Drug Use in Oslo 2002–2024
Towards elimination of hepatitis C in Oslo
Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs
The rate of hepatitis C reinfection in Canadians coinfected with HIV and its implications for national elimination
Linkage to hepatitis C virus care in a binational cohort study of People who inject drugs on the U.S.-Mexico border
Changes in hepatitis C virus prevalence and incidence among people who inject drugs in the direct acting antiviral era
Hepatitis C treatment uptake among people who inject drugs in Oslo, Norway
Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs
Epidemiology and natural history of HCV infection
Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B
Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy
Elimination of hepatitis C virus infection among people who use drugs
Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs
| Obras citantes distintas | 7 |
|---|---|
| Citas por año | 1,4 |
| Intervalo de citas | 2021 - 2026 (6) |
| Velocidad de citación | current |
| Altamente citado | No |
| Tipos de cita | Neutras: 7 |